TallyHQ
github
Client · LDA

PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA

5 filings 77 bills mentioned 1 registrants 5 quarters ~$50,110,000 reported
Client ID
138226

Bills lobbied on

Bills referenced in this client's quarterly filings, ranked by filing count.

HCONRES 14
Establishing the congressional budget for the United States Government for fiscal year 2025 and setting forth the appropriate budgetary levels for fiscal years 2026 through 2034.
BUD
5
S 1040
Drug Competition Enhancement Act
CPT
5
HR 2214
DRUG Act
HCR
5
S 652
Protecting Patients from Deceptive Drug Ads Act
HCR
5
S 43
Skinny Labels, Big Savings Act
CPT
5
HR 1574
RESTORE Patent Rights Act of 2025
CPT
5
S 891
Bipartisan Health Care Act
HCR
5
HR 890
Stopping Pharma’s Ripoffs and Drug Savings For All Act
CPT
5
HR 1262
Mikaela Naylon Give Kids a Chance Act
HCR
5
S 1041
Affordable Prescriptions for Patients Act
CPT
5
HR 1492
To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program.
HCR
5
S 932
Give Kids a Chance Act of 2025
HCR
5
S 1095
Stop STALLING Act
CPT
5
S 1097
Interagency Patent Coordination and Improvement Act of 2025
CPT
5
HR 946
ORPHAN Cures Act
HCR
5
S 1096
Preserve Access to Affordable Generics and Biosimilars Act
CPT
5
S 708
RESTORE Patent Rights Act of 2025
CPT
5
S 832
EPIC Act of 2025
HCR
5
HR 4213
Department of Homeland Security Appropriations Act, 2026
BUD
4
S 1954
Biosimilar Red Tape Elimination Act
HCR
4
S 355
FDA Modernization Act 3.0
HCR
4
HR 3269
ETHIC Act
CPT
4
S 1553
PREVAIL Act
CPT
4
HRES 566
Providing for consideration of the Senate amendment to the bill (H.R. 1) to provide for reconciliation pursuant to title II of H. Con. Res. 14.
BUD
4
S 2256
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2026
BUD
4
HR 1
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
BUDHCRMMM
4
S 1414
Expedited Access to Biosimilars Act
HCR
4
HR 3944
Military Construction and Veterans Affairs, Agriculture, and Legislative Branch Appropriations Act, 2026
BUD
4
HR 3152
Patent Eligibility Restoration Act of 2025
CPT
4
S 1546
Patent Eligibility Restoration Act of 2025
CPT
4
HR 3160
PREVAIL Act
CPT
4
HR 4121
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2026
BUD
4
S 2587
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026
BUD
3
HR 4570
Interagency Patent Coordination and Improvement Act of 2025
CPT
3
HR 5304
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026
BUD
3
S 864
HELP Copays Act
HCR
3
S 2658
Medication Affordability and Patent Integrity Act
CPTHCR
3
S 2620
REMEDY Act
CPT
3
S 2354
Commerce, Justice, Science, and Related Agencies Appropriations Act, 2026
BUD
3
HR 4317
PBM Reform Act of 2025
HCR
3
S 2276
ETHIC Act
CPT
3
HR 5342
Commerce, Justice, Science, and Related Agencies Appropriations Act, 2026
BUD
3
—
119:s:5459
HCR
3
HR 5256
340B ACCESS Act
HCR
3
S 1637
MVP Act
MMM
3
S 2296
National Defense Authorization Act for Fiscal Year 2026
BUDHCRTRD
3
HR 6423
HELP Copays Act
HCR
2
HR 6485
Skinny Labels, Big Savings Act
CPT
2
HR 4780
USTRx Act
TRD
2
S 3345
PBM Price Transparency and Accountability Act
HCR
2

Registrants

Lobbying firms that filed on behalf of this client.

PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA 5

Source: Senate LDA quarterly filings (LD-2). Bill mentions extracted from free-text "specific issues" descriptions.